bioLytical Laboratories, a world leader in rapid infectious disease tests, is pleased to announce that the INSTI HIV Self Test has received a certificate of validation from the Kenya Ministry of ...
The INSTI Hepatitis C (HCV) Antibody Test is authorized by Health Canada for immediate entry into the Canadian market The screening test is portable and can be used as an aid in diagnosis for ...
RICHMOND, BC, Dec. 1, 2016 /CNW/ - bioLytical Laboratories (the "Company"), a world leader in rapid infectious disease tests, announced today it is expanding the launch of its INSTI HIV Self Test to ...
Approval Significantly Expands U.S. Market for INSTI™ HIV-1/2 Test bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received ...
RICHMOND, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc. ("bioLytical”), a global leader in rapid infectious disease diagnostics, announces the launch of its INSTI® ...
The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG number: 448926) The screening test is portable and can be used as an aid in diagnosis ...
bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the Company's newest product, the INSTI HIV Self Test, to Kenya's Pharmaceutical Association members. With a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results